X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-26 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | GC, Corp Sec | S - Sale+OE | $3.00 | -17,756 | 173,999 | -9% | -$53,280 | |||||
2026-02-02 | ABSI | Absci Corp | McClain Sean | CEO | S - Sale | $2.99 | -26,761 | 8,334,567 | 0% | -$80,015 | ||||||
2026-02-02 | ABSI | Absci Corp | Jonasson Zachariah | CFO , CBO | S - Sale | $2.99 | -17,496 | 383,538 | -4% | -$52,313 | ||||||
| D | 2026-01-26 | AERG | Applied Energetics, Inc. | Donaghey Christopher Wayne | Pres, CEO, Principal AO | S - Sale+OE | $1.65 | -10,000 | 133,592 | -7% | -$16,500 | |||||
2026-01-28 | AIMD | Ainos, Inc. | Taiwan Carbon Nano Technology Corp | 10% | S - Sale | $2.17 | -46,000 | 989,925 | -4% | -$99,806 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Rucci Carolyn M. | SVP, GC | S - Sale | $1.39 | -69,772 | 588,378 | -11% | -$96,983 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Malabre Richard C | SVP, Chief Accounting Officer | S - Sale | $1.39 | -49,524 | 299,390 | -14% | -$68,838 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Grund Nicholas | Chief Commercial Officer | S - Sale | $1.39 | -84,829 | 561,750 | -13% | -$117,912 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres | S - Sale | $1.39 | -341,305 | 3,457,722 | -9% | -$474,414 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Ostrowski Erik | SVP, CFO, CBO, Treasurer | S - Sale | $1.39 | -34,951 | 672,635 | -5% | -$48,582 | ||||||
2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $1.39 | -67,658 | 948,432 | -7% | -$94,045 | ||||||
2026-02-26 | ALEC | Alector, Inc. | Wong-Sarad Grace | Principal Accounting Officer | S - Sale | $2.50 | -4,079 | 118,903 | -3% | -$10,198 | ||||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R, D | S - Sale+OE | $1.77 | -35,700 | 581,166 | -6% | -$63,189 | |||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Douglas Earl Martin | SVP, GC | S - Sale+OE | $1.76 | -22,900 | 564,948 | -4% | -$40,304 | |||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CFO | S - Sale+OE | $1.76 | -24,001 | 1,252,795 | -2% | -$42,242 | |||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S - Sale+OE | $1.73 | -7,549 | 210,172 | -3% | -$13,060 | |||||
| D | 2026-02-02 | ALLO | Allogene Therapeutics, Inc. | Chang David D | Pres, CEO | S - Sale+OE | $1.80 | -95,269 | 8,099,058 | -1% | -$171,484 | |||||
2026-02-18 | BRLT | Brilliant Earth Group, Inc. | Dziesietnik Sharon | Chief Operations Officer | S - Sale | $1.37 | -19,687 | 446,736 | -4% | -$26,971 | ||||||
| DM | 2026-02-17 | CDLX | Cardlytics, Inc. | Gupta Amit | CEO | S - Sale+OE | $0.91 | -97,208 | 659,644 | -13% | -$88,765 | |||||
| M | 2026-01-26 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $4.98 | -19,274 | 580,329 | -3% | -$96,045 | |||||
| M | 2026-01-29 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $4.23 | -24,770 | 555,559 | -4% | -$104,862 | |||||
2026-02-03 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $4.10 | -5,559 | 550,000 | -1% | -$22,792 | ||||||
| D | 2026-02-24 | CRBU | Caribou Biosciences, Inc. | Khan Ruhi Ahmad | Chief Business Officer | S - Sale+OE | $1.96 | -6,938 | 104,998 | -6% | -$13,598 | |||||
| D | 2026-02-24 | CRBU | Caribou Biosciences, Inc. | McClung Barbara G | GC | S - Sale+OE | $1.96 | -6,938 | 481,564 | -1% | -$13,598 | |||||
| M | 2026-02-19 | CRCT | Cricut, Inc. | Ashish Arora | CEO, 10% | S - Sale | $4.56 | -180,000 | 3,798,453 | -5% | -$821,664 | |||||
| M | 2026-01-27 | CSAI | Cloudastructure, Inc. | Bentley Sheldon Richard | Founder, 10% | S - Sale | $0.84 | -50,000 | 100,000 | -33% | -$42,000 | |||||
| M | 2026-02-03 | CSAI | Cloudastructure, Inc. | Bentley Sheldon Richard | Founder, 10% | S - Sale | $0.58 | -50,000 | 50,000 | -50% | -$29,000 | |||||
| M | 2026-02-10 | CSAI | Cloudastructure, Inc. | Bentley Sheldon Richard | Founder, 10% | S - Sale | $0.61 | -50,000 | 0 | -100% | -$30,500 | |||||
| D | 2026-02-02 | DGXX | Digi Power X Inc. | Amar Alec | Pres | S - Sale+OE | $2.53 | -27,500 | 1,308,116 | -2% | -$69,575 | |||||
2026-02-17 | DTI | Drilling Tools International Corp | Domino Michael Wayne Jr. | Pres, DTR Division | S - Sale | $3.96 | -6,249 | 1,426,805 | 0% | -$24,746 | ||||||
| D | 2026-02-18 | DTIL | Precision Biosciences Inc | Amoroso Michael | Pres, CEO | S - Sale+OE | $3.84 | -20,559 | 243,392 | -8% | -$78,947 | |||||
| D | 2026-02-18 | DTIL | Precision Biosciences Inc | Scimeca Dario | GC, Secretary | S - Sale+OE | $3.84 | -4,925 | 56,457 | -8% | -$18,912 | |||||
| D | 2026-02-18 | DTIL | Precision Biosciences Inc | Kelly John Alexander | CFO | S - Sale+OE | $3.84 | -8,149 | 125,883 | -6% | -$31,292 | |||||
| D | 2026-02-18 | DTIL | Precision Biosciences Inc | Smith J. Jefferson | Chief Research Officer | S - Sale+OE | $3.84 | -4,925 | 129,857 | -4% | -$18,912 | |||||
2026-02-04 | EGHT | 8X8 Inc /De/ | Middleton Hunter | Chief Product Officer | S - Sale | $2.50 | -85,044 | 652,943 | -12% | -$212,814 | ||||||
2026-02-17 | EGHT | 8X8 Inc /De/ | Denny Laurence | GC | S - Sale | $2.55 | -5,000 | 376,771 | -1% | -$12,732 | ||||||
| D | 2026-02-19 | EQ | Equillium, Inc. | Zedelmayer Christine | SVP, COO | S - Sale+OE | $1.76 | -185,937 | 191,444 | -49% | -$328,104 | |||||
| M | 2026-02-06 | EU | Encore Energy Corp. | Sheriff William M | See Remarks | S - Sale | $2.76 | -24,000 | 2,216,931 | -1% | -$66,240 | |||||
2026-02-02 | EXFY | Expensify, Inc. | Barrett David Michael | CEO | S - Sale | $1.45 | -30,000 | 1,531,047 | -2% | -$43,500 | ||||||
2026-01-30 | FAT | Fat Brands, Inc | Hot Gfg LLC | 10% | S - Sale | $0.27 | -1,794,766 | 1,544,623 | -54% | -$485,843 | ||||||
| D | 2026-02-19 | FLD | Fold Holdings, Inc. | Repass Wolfe | CFO | S - Sale+OE | $1.48 | -21,857 | 176,329 | -11% | -$32,436 | |||||
| DM | 2026-02-20 | FLD | Fold Holdings, Inc. | Repass Wolfe | CFO | S - Sale+OE | $1.53 | -16,585 | 198,877 | -8% | -$25,406 | |||||
| D | 2026-02-18 | GERN | Geron Corp | Robertson Michelle | EVP, CFO | S - Sale+OE | $1.94 | -9,855 | 17,645 | -36% | -$19,119 | |||||
2026-02-20 | GPRO | Gopro, Inc. | McGee Brian | EVP, CFO, COO | S - Sale | $0.79 | -59,509 | 688,922 | -8% | -$47,137 | ||||||
| M | 2026-02-23 | IRWD | Ironwood Pharmaceuticals Inc | John Minardo | GC | S - Sale | $3.73 | -36,492 | 363,886 | -9% | -$136,177 | |||||
| M | 2026-02-23 | IRWD | Ironwood Pharmaceuticals Inc | Gaskins Tammi L | Chief Commercial Officer | S - Sale | $3.73 | -21,526 | 213,738 | -9% | -$80,328 | |||||
| M | 2026-02-23 | IRWD | Ironwood Pharmaceuticals Inc | Martini Gregory S. | CFO | S - Sale | $3.73 | -21,944 | 160,601 | -12% | -$81,888 | |||||
| M | 2026-02-23 | IRWD | Ironwood Pharmaceuticals Inc | McCourt Thomas A | CEO | S - Sale | $3.73 | -198,283 | 1,489,002 | -12% | -$739,929 | |||||
| M | 2026-02-23 | IRWD | Ironwood Pharmaceuticals Inc | Shetzline Michael | SVP, CMO, Head-Res, Drug | S - Sale | $3.73 | -32,582 | 1,059,862 | -3% | -$121,586 | |||||
| M | 2026-02-23 | IRWD | Ironwood Pharmaceuticals Inc | Silver Ronald | Principal Accounting Officer | S - Sale | $3.73 | -24,173 | 252,636 | -9% | -$90,206 | |||||
| M | 2026-02-12 | ISPR | Ispire Technology Inc. | Pryzbyla Steven P. | CLO, Secretary | S - Sale | $3.29 | -9,000 | 390,664 | -2% | -$29,592 | |||||
| M | 2026-01-06 | IVFH | Innovative Food Holdings Inc | Bennett Robert William | Former CEO and Director | S - Sale | $0.33 | -2,114,440 | 377,571 | -85% | -$703,364 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Andersen Jill | GC, Secretary | S - Sale+OE | $1.56 | -67,710 | 182,236 | -27% | -$105,581 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Duke William E. | CFO | S - Sale+OE | $1.56 | -40,627 | 107,717 | -27% | -$63,350 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Lee Timothy Edward | Chief Commercial Officer | S - Sale+OE | $1.56 | -40,627 | 117,717 | -26% | -$63,350 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Allen Robert D. III | Chief Scientific Officer | S - Sale+OE | $1.56 | -37,581 | 114,487 | -25% | -$58,600 | |||||
| DM | 2026-02-17 | IVVD | Invivyd, Inc. | Green Julie | CHRO | S - Sale+OE | $1.56 | -40,627 | 107,717 | -27% | -$63,350 | |||||
| M | 2026-02-19 | JCTC | Jewett Cameron Trading Co Ltd | Oregon Community Foundation | 10% | S - Sale | $1.81 | -46,250 | 785,959 | -6% | -$83,767 | |||||
| M | 2026-02-23 | JCTC | Jewett Cameron Trading Co Ltd | Oregon Community Foundation | 10% | S - Sale | $1.80 | -7,414 | 778,545 | -1% | -$13,364 | |||||
| M | 2026-02-03 | KOS | Kosmos Energy Ltd. | Inglis Andrew G | COB, CEO | S - Sale | $1.39 | -148,182 | 4,227,017 | -3% | -$205,241 | |||||
| M | 2026-02-03 | KOS | Kosmos Energy Ltd. | Marion Josh R. | SVP, GC | S - Sale | $1.38 | -22,940 | 194,125 | -11% | -$31,592 | |||||
| M | 2026-02-03 | KOS | Kosmos Energy Ltd. | Shah Nealesh D. | SVP, CFO | S - Sale | $1.39 | -79,124 | 1,705,167 | -4% | -$109,634 | |||||
| M | 2026-02-03 | KOS | Kosmos Energy Ltd. | Glass Ronald W. | VP, Chief Accounting Officer | S - Sale | $1.38 | -22,598 | 339,632 | -6% | -$31,125 | |||||
2026-02-17 | LAW | Cs Disco, Inc. | Garcia Susan | GC, Chief Compliance Officer | S - Sale | $3.07 | -3,743 | 158,877 | -2% | -$11,491 | ||||||
2026-02-17 | LAW | Cs Disco, Inc. | Herckis Karen | EVP, CHRO | S - Sale | $3.07 | -8,171 | 201,851 | -4% | -$25,085 | ||||||
2026-02-17 | LAW | Cs Disco, Inc. | Antoon Melanie | EVP, Chief Customer Officer | S - Sale | $3.07 | -9,289 | 289,493 | -3% | -$28,517 | ||||||
2026-02-17 | LAW | Cs Disco, Inc. | Crum Richard Francis | EVP, Chief Prod, Tech Officer | S - Sale | $3.07 | -6,508 | 355,363 | -2% | -$19,980 | ||||||
| D | 2026-01-27 | LWLG | Lightwave Logic, Inc. | El-Ahmadi Siraj Nour | Dir | S - Sale+OE | $3.48 | -25,591 | 123,944 | -17% | -$89,057 | |||||
2026-02-18 | MAPS | Wm Technology, Inc. | Griffis Sarah | CTO | S - Sale | $0.68 | -271,032 | 1,528,968 | -15% | -$183,326 | ||||||
2026-02-18 | MAPS | Wm Technology, Inc. | Camire Brian | GC | S - Sale | $0.68 | -101,209 | 1,741,653 | -5% | -$68,458 | ||||||
2026-02-18 | MAPS | Wm Technology, Inc. | Francis Douglas | CEO, 10% | S - Sale | $0.68 | -103,019 | 31,437,969 | 0% | -$69,682 | ||||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Bharucha David | Chief Medical Officer | S - Sale+OE | $2.25 | -70,252 | 113,181 | -38% | -$158,209 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Nelson Jeffrey Edward | COO | S - Sale+OE | $2.25 | -70,252 | 49,848 | -58% | -$158,209 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Muller Lorenz | Chief Commercial Officer | S - Sale+OE | $2.25 | -64,746 | 205,406 | -24% | -$145,851 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Hasija Amit | CFO, EVP of Corp. Development | S - Sale+OE | $2.25 | -70,252 | 99,848 | -41% | -$158,209 | |||||
| DM | 2025-12-15 | MIST | Milestone Pharmaceuticals Inc. | Oliveto Joseph | Pres, CEO | S - Sale+OE | $2.24 | -167,577 | 482,744 | -26% | -$375,315 | |||||
2026-02-02 | MOBX | Mobix Labs, Inc | Sansone Philip | CEO | S - Sale | $0.19 | -87,025 | 1,848,816 | -4% | -$16,361 | ||||||
2026-02-17 | MQ | Marqeta, Inc. | Cummings Martha | Dir | S - Sale | $4.00 | -2,853 | 38,969 | -7% | -$11,410 | ||||||
2026-02-17 | MQ | Marqeta, Inc. | Sumner Crystal | See Remarks | S - Sale | $4.00 | -5,056 | 311,948 | -2% | -$20,212 | ||||||
| M | 2026-02-20 | MSGM | Motorsport Games Inc. | Zoi Mike | 10% | S - Sale | $3.57 | -62,828 | 1,417,557 | -4% | -$224,334 | |||||
2026-02-17 | NMRA | Neumora Therapeutics, Inc. | Pinto Joshua | Pres | S - Sale | $3.54 | -5,967 | 209,950 | -3% | -$21,093 | ||||||
2026-02-17 | NMRA | Neumora Therapeutics, Inc. | Berns Paul L | See Remarks | S - Sale | $3.51 | -9,819 | 7,794,476 | 0% | -$34,459 | ||||||
2026-02-17 | NMRA | Neumora Therapeutics, Inc. | Aurora Daljit Singh | See Remarks | S - Sale | $3.56 | -6,165 | 82,770 | -7% | -$21,917 | ||||||
2026-02-02 | NOTV | Inotiv, Inc. | Leasure Robert Jr. | Pres, CEO | S - Sale | $0.50 | -113,297 | 1,378,025 | -8% | -$57,034 | ||||||
| M | 2026-01-26 | NPWR | Net Power Inc. | Npeh, LLC | 10% | S - Sale | $2.37 | -295,220 | 1,254,780 | -19% | -$699,926 | |||||
| M | 2026-01-26 | NPWR | Net Power Inc. | 8 Rivers Capital, LLC | 10% | S - Sale | $2.37 | -295,220 | 1,254,780 | -19% | -$699,926 | |||||
2026-01-29 | NPWR | Net Power Inc. | 8 Rivers Capital, LLC | 10% | S - Sale | $2.35 | -54,780 | 1,200,000 | -4% | -$128,651 | ||||||
2026-01-29 | NPWR | Net Power Inc. | Npeh, LLC | 10% | S - Sale | $2.35 | -54,780 | 1,200,000 | -4% | -$128,651 | ||||||
| M | 2026-02-13 | NPWR | Net Power Inc. | Npeh, LLC | 10% | S - Sale | $2.11 | -175,000 | 775,000 | -18% | -$369,330 | |||||
| M | 2026-02-13 | NPWR | Net Power Inc. | 8 Rivers Capital, LLC | 10% | S - Sale | $2.11 | -175,000 | 775,000 | -18% | -$369,330 | |||||
| M | 2026-02-19 | NPWR | Net Power Inc. | 8 Rivers Capital, LLC | 10% | S - Sale | $2.11 | -188,517 | 586,483 | -24% | -$396,869 | |||||
| M | 2026-02-19 | NPWR | Net Power Inc. | Npeh, LLC | 10% | S - Sale | $2.11 | -188,517 | 586,483 | -24% | -$396,869 | |||||
| M | 2026-02-10 | NPWR | Net Power Inc. | Npeh, LLC | 10% | S - Sale | $2.04 | -250,000 | 950,000 | -21% | -$509,167 | |||||
| M | 2026-02-10 | NPWR | Net Power Inc. | 8 Rivers Capital, LLC | 10% | S - Sale | $2.04 | -250,000 | 950,000 | -21% | -$509,167 | |||||
2026-02-17 | NRDY | Nerdy Inc. | Swenson Christopher C. | GC | S - Sale | $0.97 | -32,641 | 2,022,742 | -2% | -$31,662 | ||||||
2026-02-17 | NRDY | Nerdy Inc. | Pello Jason H. | CFO | S - Sale | $0.97 | -49,814 | 2,646,235 | -2% | -$48,320 | ||||||
| M | 2026-01-15 | NSPR | Inspiremd, Inc. | Gleason Shane Thomas | Chief Commercial Officer | S - Sale | $1.62 | -61,194 | 1,139,177 | -5% | -$99,331 | |||||
| D | 2026-02-18 | OABI | Omniab, Inc. | Berkman Charles S | GC | S - Sale+OE | $1.71 | -9,673 | 392,700 | -2% | -$16,541 | |||||
| D | 2026-02-17 | OABI | Omniab, Inc. | Berkman Charles S | GC | S - Sale+OE | $1.70 | -6,990 | 383,623 | -2% | -$11,883 | |||||
| D | 2026-02-17 | OABI | Omniab, Inc. | Gustafson Kurt A | EVP, Finance, CFO | S - Sale+OE | $1.70 | -6,828 | 259,402 | -3% | -$11,608 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |